In the urology study, Vollmer and his team (115) found that in treating patients with muscle-invasive bladder cancer, the intratumoral CXCR3 chemokine system (ligands and receptor splice variants) was identified as a critical component for tumor eradication upon neoadjuvant chemotherapy. This evidence concerns the gene CXCR3 and neoplasm.